Across 156 nations, the blueprints meant to guide humanity's fight against cancer have been found to quietly omit the humans at their center. Researchers Emily Lau and Madeline Li, contributing to The Lancet Group Commission on the Human Crisis in Cancer, revealed that patient advocacy, meaningful participation, and holistic support are largely absent from the world's national cancer strategies. The disparity cuts deepest where the burden is heaviest: lower-income countries, facing the steepest rise in cancer cases, are least likely to have built care around the full dignity of those suffering
Global Cancer Plans Neglect Human-Centred Care, Study Finds
Cancer patients globally lack adequate human-centered care integration in national strategy plans, affecting quality of life and treatment outcomes.
Most plans neglected the full humanity of the people they were meant to serve.
Mark
So this study looked at 156 national cancer plans. What exactly were the researchers checking for?
Mimi
They were looking for whether the plans actually centered on patients as people—not just as cases to treat. Things like whether patients had a real voice in shaping policy, whether the plans addressed the whole person's needs, not just the medical side.
Luke
When you say "real voice," how did they measure that? Did they count mentions of patients, or did they look at actual decision-making power?
Mimi
The study assessed whether mechanisms existed for meaningful participation, not just whether the word "patient" appeared. There's a difference between consulting patients and actually building their input into how the system works.
Mark
And what did they find?
Mimi
Most plans didn't have that. Patient advocacy, public participation, holistic care—these were rarely woven into the actual strategy. The plans tended to focus on clinical outcomes: detection rates, treatment protocols, survival numbers.
Luke
But we should be careful here—the source doesn't give us the exact percentages or breakdowns. We know these elements were "rarely included," but we don't have the granular data on how many plans included what.
Mimi
That's fair. What we do know is there was a clear pattern, and it held across income levels—though wealthier countries did somewhat better.
Mark
Why would income level matter so much?
Mimi
Richer countries have more resources, more developed civil society, more patient advocacy groups already in place. Lower-income countries, which are actually seeing cancer rates rise fastest, had the least human-centered planning.
Luke
So the places with the most urgent need had the least developed response. That's the real story.
Mimi
Exactly. And the researchers framed it as part of a larger "human crisis in cancer"—suggesting this isn't just a policy gap, it's a failure to recognize cancer as a human problem, not just a medical one.
Mark
What happens next? Does this change anything?
Mimi
That's the open question. The research is part of a Lancet Commission, so there's institutional weight behind it. But whether governments actually use it to reshape their plans—that's still to be seen.
Le Pouls
- Cancer strategies governing billions in spending across 156 countries were found to systematically exclude the voices, needs, and participation of the patients they are designed to serve.
- The absence is not incidental — patient advocacy appeared rarely, public participation was largely tokenistic, and psychological, financial, and social dimensions of care were routinely sidelined in favor of narrow clinical metrics.
- The disparity across income levels sharpens the crisis: wealthier nations showed marginally better integration of human-centered elements, while lower-income countries — where cancer burdens are rising fastest — lag furthest behind.
- The findings now feed directly into The Lancet Group Commission on the 'Human Crisis in Cancer,' framing the evidence as a call for governments to fundamentally rethink cancer planning as a matter of human dignity, not just medical efficiency.
- Frontline clinicians and patient advocates say the research confirms what they have long witnessed — that national plans, however technically detailed, are often built around disease rather than around people.
Across 156 nations, the blueprints meant to guide humanity's fight against cancer have been found to quietly omit the humans at their center. Researchers Emily Lau and Madeline Li, contributing to The Lancet Group Commission on the Human Crisis in Cancer, revealed that patient advocacy, meaningful participation, and holistic support are largely absent from the world's national cancer strategies. The disparity cuts deepest where the burden is heaviest: lower-income countries, facing the steepest rise in cancer cases, are least likely to have built care around the full dignity of those suffering. What this study names is not merely a policy gap, but a philosophical failure — the reduction of a human crisis into a clinical management problem.
A major cross-sectional analysis of 156 national cancer strategy plans has exposed a profound and systemic gap: the frameworks guiding global cancer policy rarely center on the lived experience of those with the disease. Led by researchers Emily Lau and Madeline Li, the study assessed not merely whether patient voices were mentioned, but whether national plans embedded real mechanisms for patients and communities to shape decisions — and whether care models acknowledged the full spectrum of human need.
What the researchers found was a portrait of systematic neglect. Most plans concentrated narrowly on clinical outcomes — detection rates, treatment protocols, survival statistics — while leaving aside the dimensions that determine whether a person can truly live through and beyond cancer: mental health support, financial assistance, community connection, and the space to be heard. Patient advocacy, where it appeared at all, was largely symbolic rather than structural.
The income divide compounded the concern. Wealthier nations, with stronger civil society infrastructure, were somewhat more likely to incorporate human-centered elements. But lower-income countries — where cancer burdens are growing fastest and resources are most stretched — were least likely to have designed their strategies around the full humanity of patients. Those facing the steepest challenges are also least likely to encounter systems built with them in mind.
The study contributes to The Lancet Group Commission on the 'Human Crisis in Cancer,' led by Gary Rodin and Richard Sullivan — a framing that signals the stakes clearly. Cancer is not only a medical crisis but a crisis of how societies respond to suffering and whether institutions are built to support whole people. The research now places concrete evidence behind what clinicians and advocates have long argued: that national cancer strategies, for all their technical ambition, too often leave out the very people they exist to serve.
A sweeping examination of how the world's nations plan to fight cancer has uncovered a troubling gap: the strategies that guide billions in spending and shape millions of lives rarely center on the people actually living with the disease. Researchers led by Emily Lau and Madeline Li analyzed 156 national cancer strategy plans—one from each country studied—and found that core elements of human-centered care, including patient advocacy, meaningful public participation, and holistic support that extends beyond end-of-life palliative measures, were conspicuously absent from most documents.
The study, titled "A cross-sectional global policy analysis of the human gap in 156 national cancer strategy plans," represents a systematic reckoning with how governments worldwide approach cancer as a policy problem. The research team, which included oncologists, public health specialists, and patient advocates from institutions across multiple continents, did not simply count mentions of patient voices in these plans. They assessed whether the frameworks actually embedded mechanisms for patients and communities to shape decisions, whether care models acknowledged the full spectrum of a person's needs—psychological, social, financial, practical—and whether the plans moved beyond treating cancer as a purely medical event to be managed at the end of life.
What emerged was a portrait of systematic neglect. The vast majority of the 156 plans examined did not meaningfully integrate patient advocacy into their structure. Public participation, when mentioned at all, appeared tokenistic rather than substantive. The plans tended to focus narrowly on clinical interventions—detection, treatment, survival rates—while sidelining the dimensions of care that determine whether a person can actually live during and after cancer: access to mental health support, financial assistance, help navigating the healthcare system, community connection, and the space to voice what matters most to them.
The disparities across countries of different income levels added another layer of concern. Wealthier nations, with greater resources and more developed civil society infrastructure, were somewhat more likely to incorporate human-centered elements into their cancer strategies. Lower-income countries, where the burden of cancer is rising fastest and resources are most constrained, were least likely to have built patient-centered approaches into their national plans. This gap means that people in the countries facing the steepest cancer challenges are also least likely to encounter healthcare systems designed with their full humanity in mind.
The work emerges from a larger initiative: The Lancet Group Commission on the "Human Crisis in Cancer," led by Gary Rodin and Richard Sullivan. That framing—a human crisis—signals how the researchers and their collaborators understand what is at stake. Cancer is not only a medical crisis; it is a crisis of how societies respond to suffering, how they value the voices of those affected, and whether their institutions are built to support whole people or merely to process disease. The commission's work suggests that many national cancer strategies, despite their technical sophistication and investment, are failing on this fundamental measure.
Dario Trapani, a medical oncologist at the IEO European Institute of Oncology, highlighted the study's findings on professional networks, underscoring that the gap between what cancer strategy plans contain and what human-centered care actually requires has become impossible to ignore. The research provides concrete evidence of what patient advocates and frontline clinicians have long observed: that national cancer strategies, for all their detail and resources, often leave out the very people they are meant to serve. The question now is whether this evidence will prompt governments and health systems to fundamentally rethink how they plan for cancer—not as a technical problem to be solved, but as a human crisis requiring the full participation and dignity of those living through it.
Citations marquantes
Key human-centered elements, such as patient advocacy, public participation, and broader holistic care beyond palliative support were rarely included.— Dario Trapani, Medical Oncologist at IEO European Institute of Oncology, summarizing the study findings
Envie de l'histoire complète ?
Lire l'original sur Oncodaily ↗